Details

---

Manufacturer
PATHEON ITALIA S.P.A.(ITALY)

Registraction Number
MAL09102944ACRZ

Content:
Keppra Concentrate for Solution for Infusion contains 500 mg of levetiracetam per 5 mL of solution. It is a clear, colorless solution intended for intravenous administration1.
Indications:
Keppra is indicated for the treatment of:

• Partial-onset seizures in patients aged 1 month and older.
• Myoclonic seizures in patients with juvenile myoclonic epilepsy.
• Primary generalized tonic-clonic seizures.

Instructions:

1. Dilution: The solution should be diluted in 100 mL of a compatible diluent such as sodium chloride (0.9%) injection, lactated Ringer's injection, or dextrose 5% injection.
2. Administration: Administer the diluted solution intravenously as a 15-minute infusion.
3. Dosage: The typical dosage for adults is 1000 mg per day, given as 500 mg twice daily. The dosage may be adjusted based on the patient's response and tolerance2.
4. Monitoring: Patients should be monitored for any adverse reactions, including behavioral abnormalities and psychotic symptoms.